| Application no. and date | 18205194.6 (espacenet) (Federated) (European Patent Register), 20141022 | | Patent/reg. no. and date | DK/EP 3501605, 20230628 | | Publication date | 20190626 | | Priority no. and date | US 201361894294 P, 20131022 | | EP pub. no. and date |
EP 3501605 20190626 | | Effective date | | | Applicant/owner | Translate Bio, Inc., 200 West Street
Waltham, MA 02451, US | | Applicant ref. no. | | | Inventor | HEARTLEIN, Michael, 300 Shire Way
Lexington, MA Massachusetts 02421, US,
DEROSA, Frank, 300 Shire Way
Lexington, MA Massachusetts 02421, US,
SMITH, Lianne, 300 Shire Way
Lexington, MA Massachusetts 02421, US | | Representative | | | Opponent | | | IPC Class | A61K 31/7105 (2006.01) , A61K 38/53 (2006.01) , A61K 48/00 (2006.01) , A61K 9/127 (2006.01) , A61K 9/51 (2006.01) , A61P 3/00 (2006.01) , C12N 9/00 (2006.01) | | Title | MRNA THERAPY FOR ARGININOSUCCINATE SYNTHETASE DEFICIENCY | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
